Ventas, Inc.
Close on Oct 19, 2026
- Market cap
- $42.06B
- P/E (TTM)
- 156.5
- Dividend yield
- 2.27%
About Ventas
Real Estate Investment Trusts, SIC 6798
Ventas, Inc. is a real estate investment trust that acquires, develops, leases, and manages healthcare-related properties. The company conducts business through three primary segments: the senior housing operating portfolio, the outpatient medical and research portfolio, and triple-net leased properties. Its asset types include independent and assisted living facilities, memory care and continuing care retirement centers, outpatient medical buildings, research laboratories, and specialized care facilities like skilled nursing and long-term acute care centers. Ventas provides environments and advisory services for healthcare providers, hospital networks, universities, academic medical centers, biotechnology and pharmaceutical firms, facility managers, and senior residents.
The company holds ownership or investment interests in 1,409 properties, consisting of 1,374 segment assets and 35 unconsolidated real estate properties. Its portfolio is geographically diversified across the United States, Canada, and the United Kingdom. Ventas is headquartered in Chicago, Illinois, and maintains additional corporate offices in Louisville, Kentucky, and New York, New York.
Summary of the business section of Ventas's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Ventas, Inc.
- Founded
- 1998
- Headquarters
- Chicago, IL
- Address
- 300 N Lasalle Street, Suite 1600 60654
- Phone
- (312) 660-3800
- Website
- www.ventasreit.com
- Employees
- 542, Dec 31, 2025
- Industry
- Real Estate Investment Trusts
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Chicago, Illinois
Stock & identifiers
- Ticker
- VTR
- Exchange
- NYSE
- Shares outstanding
- 513M, Jul 28, 2026
- Public float
- $28.60B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 740260
- CUSIP
- 92276F100
- ISIN
- US92276F1003
- LEI
- ORQTRC074CWLT3DKHT41
- EIN
- 61-1055020
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Debra A. Cafaro | Chairman and CEO, Director | 1,427,102 |
| Andy Wattula | EVP OM&R-Ventas/Pres&CEO-LHS | 10,694 |
| Peter J. Bulgarelli | EVP OM&R-Ventas/Pres&CEO-LHS | 120,554 |
| Carey S. Roberts | EVP and GC | 72,755 |
| James Justin Hutchens | EVP Senior Housing and CIO | 179,232 |
| Robert F. Probst | EVP and CFO | 169,734 |
| Gregory R. Liebbe | SVP, Chief Accounting Officer | 13,901 |
| Michael J. Embler | Director | 19,274 |
| Melody C. Barnes | Director | 35,379 |
| Matthew J. Lustig | Director | 95,663 |
| Maurice S. Smith | Director | 31,240 |
| Joe Vasquez Rodriguez Jr. | Director | 9,943 |
| Roxanne M. Martino | Director | 66,846 |
| Marguerite M. Nader | Director | 23,544 |
| Sumit Roy | Director | 24,800 |
| Walter C. Rakowich | Director | 28,349 |
| Theodore Bigman | Director | 10,640 |
| Sean P. Nolan | Director | 26,331 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Debra A. Cafaro | $17.50M | $40.51M | $5.30M | $187 | $165 |
| FY2024 Debra A. Cafaro | $14.44M | $21.87M | $4.33M | $139 | $128 |
| FY2023 Debra A. Cafaro | $13.52M | $10.14M | $4.11M | $113 | $103 |
| FY2022 Debra A. Cafaro | $14.06M | $17.81M | $4.22M | $99 | $91 |
| FY2021 Debra A. Cafaro | $14.26M | $9.91M | $6.01M | $108 | $116 |
| FY2020 Debra A. Cafaro | $12.63M | $9.44M | $5.40M | $90 | $90 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 542 employees, none of which are subject to a collective bargaining agreement.”
Corporate history
Events identified from SEC filings